AACTG A5095, Trizivir, and the role of all-nucleoside regimens: an editorial.

Joel E. Gallant

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1-2
Number of pages	2
Journal	The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service
Volume	15
Issue number	4
State	Published - 2003
Externally published	Yes

Cite this

@article{b1eb9a8217bf4addbc76937392f3cb04,

title = "AACTG A5095, Trizivir, and the role of all-nucleoside regimens: an editorial.",

author = "Gallant, {Joel E.}",

year = "2003",

language = "English (US)",

volume = "15",

pages = "1--2",

journal = "The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service",

issn = "1551-8396",

publisher = "Johns Hopkins University Press",

number = "4",

}

TY - JOUR

T1 - AACTG A5095, Trizivir, and the role of all-nucleoside regimens

T2 - an editorial.

AU - Gallant, Joel E.

PY - 2003

Y1 - 2003

UR - http://www.scopus.com/inward/record.url?scp=0642307097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642307097&partnerID=8YFLogxK

M3 - Article

C2 - 14696559

AN - SCOPUS:0642307097

SN - 1551-8396

VL - 15

SP - 1

EP - 2

JO - The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service

JF - The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service

IS - 4

ER -